BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tsilimigras DI, Moris D, Hyer JM, Bagante F, Sahara K, Moro A, Paredes AZ, Mehta R, Ratti F, Marques HP, Silva S, Soubrane O, Lam V, Poultsides GA, Popescu I, Alexandrescu S, Martel G, Workneh A, Guglielmi A, Hugh T, Aldrighetti L, Endo I, Sasaki K, Rodarte AI, Aucejo FN, Pawlik TM. Hepatocellular carcinoma tumour burden score to stratify prognosis after resection. Br J Surg 2020;107:854-64. [PMID: 32057105 DOI: 10.1002/bjs.11464] [Cited by in Crossref: 18] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Ho S, Liu P, Hsu C, Huang Y, Liao J, Su C, Hou M, Huo T. Radiofrequency Ablation versus Transarterial Chemoembolization for Hepatocellular Carcinoma within Milan Criteria: Prognostic Role of Tumor Burden Score. Cancers 2022;14:4207. [DOI: 10.3390/cancers14174207] [Reference Citation Analysis]
2 Moazzam Z, Lima HA, Alaimo L, Endo Y, Shaikh CF, Ratti F, Marques HP, Soubrane O, Lam V, Poultsides GA, Popescu I, Alexandrescu S, Martel G, Guglielmi A, Hugh T, Aldrighetti L, Endo I, Pawlik TM. Impact of tumor burden score on timing and patterns of recurrence after curative-intent resection of hepatocellular carcinoma. Surgery 2022:S0039-6060(22)00570-0. [PMID: 36031442 DOI: 10.1016/j.surg.2022.07.019] [Reference Citation Analysis]
3 Ho SY, Liu PH, Hsu CY, Huang YH, Liao JI, Su CW, Hou MC, Huo TI. Tumor burden score as a new prognostic surrogate in patients with hepatocellular carcinoma undergoing radiofrequency ablation: role of albumin-bilirubin (ALBI) grade vs easy ALBI grade. Expert Rev Gastroenterol Hepatol 2022. [PMID: 35999514 DOI: 10.1080/17474124.2022.2117156] [Reference Citation Analysis]
4 Tsilimigras DI, Aziz H, Pawlik TM. Critical Analysis of the Updated Barcelona Clinic Liver Cancer (BCLC) Group Guidelines. Ann Surg Oncol 2022. [PMID: 35854026 DOI: 10.1245/s10434-022-12242-4] [Reference Citation Analysis]
5 Wang J, Chen Z, Wang L, Feng S, Qiu Q, Chen D, Li N, Xiao Y. A new model based inflammatory index and tumor burden score (TBS) to predict the recurrence of hepatocellular carcinoma (HCC) after liver resection. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-12518-5] [Reference Citation Analysis]
6 Lian D, Wang W, Liu L, Wang J, Rao S, Zhou J. CT volumetry helps predict prognosis of large hepatocellular carcinoma after resection. Clin Radiol 2022:S0009-9260(22)00176-3. [PMID: 35483982 DOI: 10.1016/j.crad.2022.03.018] [Reference Citation Analysis]
7 Li H, Liu R, Qiu H, Huang Y, Liu W, Li J, Wu H, Wang G, Li D. Tumor Burden Score Stratifies Prognosis of Patients With Intrahepatic Cholangiocarcinoma After Hepatic Resection: A Retrospective, Multi-Institutional Study. Front Oncol 2022;12:829407. [PMID: 35330712 DOI: 10.3389/fonc.2022.829407] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Müller L, Hahn F, Auer TA, Fehrenbach U, Gebauer B, Haubold J, Zensen S, Kim MS, Eisenblätter M, Diallo TD, Bettinger D, Steinle V, Chang DH, Zopfs D, Pinto Dos Santos D, Kloeckner R. Tumor Burden in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Head-to-Head Comparison of Current Scoring Systems. Front Oncol 2022;12:850454. [PMID: 35280804 DOI: 10.3389/fonc.2022.850454] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Papaconstantinou D, Hewitt DB, Brown ZJ, Schizas D, Tsilimigras DI, Pawlik TM. Patient stratification in hepatocellular carcinoma: impact on choice of therapy. Expert Rev Anticancer Ther 2022. [PMID: 35157530 DOI: 10.1080/14737140.2022.2041415] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Ho SY, Liu PH, Hsu CY, Huang YH, Liao JI, Su CW, Hou MC, Huo TI. A New Tumor Burden Score and Albumin-Bilirubin Grade-Based Prognostic Model for Hepatocellular Carcinoma. Cancers (Basel) 2022;14:649. [PMID: 35158917 DOI: 10.3390/cancers14030649] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Zhang XF, Xue F, Bagante F, Ratti F, Marques HP, Silva S, Soubrane O, Lam V, Poultsides GA, Popescu I, Grigorie R, Alexandrescu S, Martel G, Workneh A, Guglielmi A, Hugh T, Aldrighetti L, Lv Y, Pawlik TM. Non-transplantable Recurrence After Resection for Transplantable Hepatocellular Carcinoma: Implication for Upfront Treatment Choice. J Gastrointest Surg 2021. [PMID: 34797558 DOI: 10.1007/s11605-021-05206-8] [Reference Citation Analysis]
12 Gao S, Zhu D, Zhu J, Shen L, Zhu M, Ren X. Screening Hub Genes of Hepatocellular Carcinoma Based on Public Databases. Comput Math Methods Med 2021;2021:7029130. [PMID: 34737790 DOI: 10.1155/2021/7029130] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Machairas N, Tsilimigras DI, Pawlik TM. State-of-the-art surgery for hepatocellular carcinoma. Langenbecks Arch Surg 2021;406:2151-62. [PMID: 34405284 DOI: 10.1007/s00423-021-02298-3] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
14 Takayama T, Yamazaki S, Matsuyama Y, Midorikawa Y, Shiina S, Izumi N, Hasegawa K, Kokudo N, Sakamoto M, Kubo S, Kudo M, Murakami T, Nakashima O; Liver Cancer Study Group of Japan. Prognostic grade for resecting hepatocellular carcinoma: multicentre retrospective study. Br J Surg 2021;108:412-8. [PMID: 33793713 DOI: 10.1093/bjs/znaa109] [Reference Citation Analysis]
15 Tsilimigras DI, Pawlik TM. Prognostication in hepatocellular carcinoma: is it a burden or a ticket? Br J Surg 2021;108:337-9. [PMID: 33734326 DOI: 10.1093/bjs/znaa167] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
16 Elfadaly AN, Tsilimigras DI, Hyer JM, Paro A, Bagante F, Ratti F, Marques HP, Soubrane O, Lam V, Poultsides GA, Popescu I, Alexandrescu S, Martel G, Workneh A, Guglielmi A, Hugh T, Aldrighetti L, Endo I, Pawlik TM. Impact of Tumor Burden Score on Conditional Survival after Curative-Intent Resection for Hepatocellular Carcinoma: A Multi-Institutional Analysis. World J Surg 2021. [PMID: 34341844 DOI: 10.1007/s00268-021-06265-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Ho SY, Liu PH, Hsu CY, Ko CC, Huang YH, Su CW, Lee RC, Tsai PH, Hou MC, Huo TI. Tumor burden score as a new prognostic marker for patients with hepatocellular carcinoma undergoing transarterial chemoembolization. J Gastroenterol Hepatol 2021. [PMID: 34159651 DOI: 10.1111/jgh.15593] [Reference Citation Analysis]
18 Ding G, Zeng Y, Yang D, Zhang C, Mao C, Xiao E, Kang Y, Shang J. Silenced lncRNA DDX11-AS1 or up-regulated microRNA-34a-3p inhibits malignant phenotypes of hepatocellular carcinoma cells via suppression of TRAF5. Cancer Cell Int 2021;21:179. [PMID: 33752668 DOI: 10.1186/s12935-021-01847-6] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
19 Tsilimigras DI, Sahara K, Hyer JM, Diaz A, Moris D, Bagante F, Guglielmi A, Ruzzenente A, Alexandrescu S, Poultsides G, Sasaki K, Aucejo F, Ejaz A, Cloyd JM, Pawlik TM. Trends and outcomes of simultaneous versus staged resection of synchronous colorectal cancer and colorectal liver metastases. Surgery 2021;170:160-6. [PMID: 33674128 DOI: 10.1016/j.surg.2021.01.041] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
20 Tsilimigras DI, Hyer JM, Diaz A, Bagante F, Ratti F, Marques HP, Soubrane O, Lam V, Poultsides GA, Popescu I, Alexandrescu S, Martel G, Workneh A, Guglielmi A, Hugh T, Aldrighetti L, Endo I, Pawlik TM. Synergistic Impact of Alpha-Fetoprotein and Tumor Burden on Long-Term Outcomes Following Curative-Intent Resection of Hepatocellular Carcinoma. Cancers (Basel) 2021;13:747. [PMID: 33670174 DOI: 10.3390/cancers13040747] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Tsilimigras DI, Pawlik TM. ASO Author Reflections: Tumor Burden in Intrahepatic Cholangiocarcinoma. Ann Surg Oncol 2021;28:1979-80. [PMID: 33393044 DOI: 10.1245/s10434-020-09419-0] [Reference Citation Analysis]
22 Tsilimigras DI, Hyer JM, Bagante F, Guglielmi A, Ruzzenente A, Alexandrescu S, Poultsides G, Sasaki K, Aucejo F, Pawlik TM. Resection of Colorectal Liver Metastasis: Prognostic Impact of Tumor Burden vs KRAS Mutational Status. J Am Coll Surg 2021;232:590-8. [PMID: 33383214 DOI: 10.1016/j.jamcollsurg.2020.11.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
23 Tsilimigras DI, Mehta R, Paredes AZ, Moris D, Sahara K, Bagante F, Ratti F, Marques HP, Silva S, Soubrane O, Lam V, Poultsides GA, Popescu I, Grigorie R, Alexandrescu S, Martel G, Workneh A, Guglielmi A, Hugh T, Aldrighetti L, Endo I, Spolverato G, Umberto C, Pawlik TM. Overall Tumor Burden Dictates Outcomes for Patients Undergoing Resection of Multinodular Hepatocellular Carcinoma Beyond the Milan Criteria. Ann Surg 2020;272:574-81. [PMID: 32932309 DOI: 10.1097/SLA.0000000000004346] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
24 Moris D, Shaw BI, McElroy L, Barbas AS. Using Hepatocellular Carcinoma Tumor Burden Score to Stratify Prognosis after Liver Transplantation. Cancers (Basel) 2020;12:E3372. [PMID: 33202588 DOI: 10.3390/cancers12113372] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
25 Tsilimigras DI, Hyer JM, Diaz A, Moris D, Bagante F, Ratti F, Marques HP, Soubrane O, Lam V, Poultsides GA, Popescu I, Alexandrescu S, Martel G, Workneh A, Guglielmi A, Hugh T, Aldrighetti L, Endo I, Pawlik TM. Impact of time-to-surgery on outcomes of patients undergoing curative-intent liver resection for BCLC-0, A and B hepatocellular carcinoma. J Surg Oncol 2021;123:381-8. [PMID: 33174627 DOI: 10.1002/jso.26297] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
26 Huo TI, Liu PH, Hsu CY. Tumour burden score for hepatocellular carcinoma: Is it an authentic prognostic marker? Br J Surg 2020;107:e625. [PMID: 32955113 DOI: 10.1002/bjs.11927] [Reference Citation Analysis]
27 Tsilimigras DI, Mehta R, Guglielmi A, Ratti F, Marques HP, Soubrane O, Lam V, Poultsides GA, Popescu I, Alexandrescu S, Martel G, Hugh T, Aldrighetti L, Endo I, Pawlik TM. Recurrence beyond the Milan criteria after curative-intent resection of hepatocellular carcinoma: A novel tumor-burden based prediction model. J Surg Oncol 2020;122:955-63. [PMID: 32602143 DOI: 10.1002/jso.26091] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
28 Wigmore SJ. Advances in liver surgery. British Journal of Surgery 2020;107:788-9. [DOI: 10.1002/bjs.11624] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]